| Literature DB >> 27986455 |
Yannick Simoni1, Michael Fehlings2, Henrik N Kløverpris3, Naomi McGovern2, Si-Lin Koo4, Chiew Yee Loh2, Shawn Lim2, Ayako Kurioka5, Joannah R Fergusson5, Choong-Leong Tang6, Ming Hian Kam6, Koh Dennis7, Tony Kiat Hon Lim8, Alexander Chung Yaw Fui9, Chan Weng Hoong10, Jerry Kok Yen Chan11, Maria Curotto de Lafaille12, Sriram Narayanan13, Sonia Baig14, Muhammad Shabeer14, Sue-Anne Ee Shiow Toh15, Henry Kun Kiaang Tan16, Rosslyn Anicete16, Eng-Huat Tan4, Angela Takano8, Paul Klenerman5, Alasdair Leslie17, Daniel S W Tan18, Iain Beehuat Tan19, Florent Ginhoux2, Evan W Newell20.
Abstract
Animal models have highlighted the importance of innate lymphoid cells (ILCs) in multiple immune responses. However, technical limitations have hampered adequate characterization of ILCs in humans. Here, we used mass cytometry including a broad range of surface markers and transcription factors to accurately identify and profile ILCs across healthy and inflamed tissue types. High dimensional analysis allowed for clear phenotypic delineation of ILC2 and ILC3 subsets. We were not able to detect ILC1 cells in any of the tissues assessed, however, we identified intra-epithelial (ie)ILC1-like cells that represent a broader category of NK cells in mucosal and non-mucosal pathological tissues. In addition, we have revealed the expression of phenotypic molecules that have not been previously described for ILCs. Our analysis shows that human ILCs are highly heterogeneous cell types between individuals and tissues. It also provides a global, comprehensive, and detailed description of ILC heterogeneity in humans across patients and tissues.Entities:
Keywords: CyTOF; ILC; ILC1; ILC2; ILC3; human; ieILC1
Mesh:
Year: 2016 PMID: 27986455 PMCID: PMC7612935 DOI: 10.1016/j.immuni.2016.11.005
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 43.474